So right now these studies are under investigation but we are hopeful that a de-escalation therapy will mean patients will need less androgen deprivation therapy, less use of ARPIs which will result in a subsequent improvement in quality of life as well as decrease in financial toxicity. They will have less fatigue, they may have better sexual function, they may have better cardiovascular outcomes and they may preserve their bone health, muscle mass and may have less side effects such as fatigue and hot flashes...
So right now these studies are under investigation but we are hopeful that a de-escalation therapy will mean patients will need less androgen deprivation therapy, less use of ARPIs which will result in a subsequent improvement in quality of life as well as decrease in financial toxicity. They will have less fatigue, they may have better sexual function, they may have better cardiovascular outcomes and they may preserve their bone health, muscle mass and may have less side effects such as fatigue and hot flashes. So that’s what our belief is. And for this study, we are doing ecological momentary assessments, as well as various patient-related outcomes. And we are hopeful that in the next few years, we will be presenting these results for the patients and other caregivers.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
